AT-5214
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AT-5214, covering 2021-07-22 to 2021-07-22. Get the full timeline:
Most recent: Clinical Trial Update: Clinical Study to Assess the Efficacy and Safety of AT-5214 in the Treatment of Subjects With Palmar Hyperhidrosis [Phase 2]